Celmatix

Celmatix is a personalized medicine company that uses big data and predictive analytics to help individuals who are struggling to have a baby make informed decisions. Founded in 2009 and based in New York City, Celmatix is disrupting the way women approach their lifelong fertility journey by empowering them through science and technology. The company’s flagship Polaris product, in use at top fertility clinics across the country, is the world’s first analytics platform for optimizing fertility. Celmatix also has an active research and development program dedicated to decoding the genetic basis of fertility potential.
Company Growth (employees)
Type
Private
HQ
New York, US
Founded
2009
Size (employees)
99 (est)-1%
Celmatix was founded in 2009 and is headquartered in New York, US

Celmatix Office Locations

Celmatix has an office in New York
New York, US (HQ)
14 Wall St

Celmatix Data and Metrics

Summary Metrics

Founding Date

2009

Total Funding

$18.3 m

Latest funding size

$4.8 m

Time since last funding

over 1 year

Investors

Celmatix's latest funding round in April 2016 was reported to be $4.8 m. In total, Celmatix has raised $18.3 m

Traffic Overview of Celmatix

Celmatix Online and Social Media Presence

Celmatix News and Updates

Celmatix Wants To Help Women Conceive With This New DNA-Based Fertility Test

The company calls it the "holy grail," and says it can help women make data-driven decisions about their reproductive health. The company calls it the "holy grail," and says it can help women make data-driven decisions about their reproductive health.Piraye Yurttas Beim was dia…

Women’s health startup Celmatix now offers genetic testing for fertility issues

 Celmatix, a startup with a focus on personalized medicine for women, wants to take some of the mystery out of the science of baby-making with a new type of DNA-based fertility test called Fertilome. Fertilome looks at 49 variants in 32 genes that give you a likelihood or not for inherited disorders…

Celmatix Company Life and Culture

You may also be interested in